−0.11USD
−23.55 MUSD
872.00 MUSD
139.59 M
About Hims & Hers Health, Inc.
Sector
Industry
CEO
Andrew Dudum
Website
Headquarters
San Francisco
Employees (FY)
1.05 K
Founded
2017
ISIN
US4330001060
FIGI
BBG00Q53VYM7
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
HIMS a gender focused health care company LONGHIMS had an excellent earnings report for a small cap company; it is consumer driven quality
focused and helps the customer feel good about him/her- self. It does not have any gender
orientation agenda nor any obvious political inclinations. On the 120 minute chart, it started
a moving averg
Hims (HIMS) Stock Chart Analysis: Observing a Cup and HandleThe HIMS stock chart displays a pattern resembling a cup and handle. If confirmed, technical analysis suggests a possible price target exceeding $24.
While the cup and handle pattern suggests a potential price increase, it's important to consider other factors that can influence the stock price, suc
HIMS & HERS Short Before NEW HIGHSGood day traders, I am seeking a short term reversal to close the gap. Once the new low is set, will be looking into loading around the $4.62 area. Remember, entry is everything. Once new low is set, target is set to $13.36.
Hope you enjoy this setup, Happy Trading & BE BLESSED!
HIMS, 3/1-3/8, 9.5% profitOn 2/26/2024, Hims & Hers Health (HIMS) reported earnings of $0.01 per share on revenue of $246.62 million for the fourth quarter ended December 2023. The consensus estimate was a loss of $0.02 per share on revenue of $245.82 million.
HIMS Hims & Hers Health Options Ahead of EarningsAnalyzing the options chain and the chart patterns of HIMS Hims & Hers Health prior to the earnings report this week,
I would consider purchasing the 9usd strike price Calls with
an expiration date of 2024-3-15,
for a premium of approximately $1.12.
If these options prove to be profitable prior to t
RiskMastery's Breakout Stocks - HIMS EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential.
In this edition, we'll be looking at NYSE:HIMS ...
I believe this code is at a point of potential volatility.
If price can hold above $10.05 ... Bullish potential may be unlocked.
My key upside targets include:
$HIMS - Which is it?NYSE:HIMS reached the wedge breakout target and is currently consolidating between the 50% and 38.2% Fib retracement levels.
There is an inverse head and shoulders (IHS) forming, and the neckline happens to be the Point of Control (POC) volume resistance + 50% Fib retracement.
It needs a successf
HIMS - Gorgeous set upIncredible symmetry is unmistakable. IMO, this is at least testing the trendline. How it holds there would decide eventual break out this pattern. Would be a good spot for the long investors.
Update on HIMs GAPThis Hims GAP play has worked out very well with some washouts that I had to hold through. You can see my entry with the dotted green line which I normally do for transparency. My entrance was after the confirmation of the breakout on that medium term downtrend (purple line) HIMs did have some issue
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HIMS is 12.78 USD — it has decreased by 3.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Hims & Hers Health, Inc. stocks are traded under the ticker HIMS.
Hims & Hers Health, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Hims & Hers Health, Inc. has a max estimate of 20.00 USD and a min estimate of 11.00 USD.
HIMS earnings for the last quarter are −0.04 USD whereas the estimation was −0.04 USD which accounts for −12.09% surprise. Estimated earnings for the next quarter are −0.02 USD. See more details about Hims & Hers Health, Inc. earnings.
Hims & Hers Health, Inc. revenue for the last quarter amounts to 226.70 M USD despite the estimated figure of 220.08 M USD. In the next quarter revenue is expected to reach 246.47 M USD.
Yes, you can track Hims & Hers Health, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, HIMS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hims & Hers Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 1.05 K employees. See our rating of the largest employees — is Hims & Hers Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hims & Hers Health, Inc. EBITDA is −26.42 M USD, and current EBITDA margin is −2.75%. See more stats in Hims & Hers Health, Inc. financial statements.